APA (7th ed.) Citation

Sander, B. A., Monberg, T. J., Hodzic‐Hadzibegovic, D., Larsen, M., & Lund‐Andersen, H. (2018). Diabetic macular oedema treated with intravitreal anti‐vascular endothelial growth factor – 2–4 years follow‐up of visual acuity and retinal thickness in 566 patients following Danish national guidelines. Acta Ophthalmologica (1755375X), 96(3), 267. https://doi.org/10.1111/aos.13638

Chicago Style (17th ed.) Citation

Sander, Birgit Agnes, Tine Juul Monberg, Delila Hodzic‐Hadzibegovic, Michael Larsen, and Henrik Lund‐Andersen. "Diabetic Macular Oedema Treated with Intravitreal Anti‐vascular Endothelial Growth Factor – 2–4 years Follow‐up of Visual Acuity and Retinal Thickness in 566 Patients Following Danish National Guidelines." Acta Ophthalmologica (1755375X) 96, no. 3 (2018): 267. https://doi.org/10.1111/aos.13638.

MLA (9th ed.) Citation

Sander, Birgit Agnes, et al. "Diabetic Macular Oedema Treated with Intravitreal Anti‐vascular Endothelial Growth Factor – 2–4 years Follow‐up of Visual Acuity and Retinal Thickness in 566 Patients Following Danish National Guidelines." Acta Ophthalmologica (1755375X), vol. 96, no. 3, 2018, p. 267, https://doi.org/10.1111/aos.13638.